Brokerages predict that The Joint Corp. (NASDAQ:JYNT – Get Rating) will post $0.04 earnings per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Joint’s earnings. The highest EPS estimate is $0.06 and the lowest is $0.02. Joint reported earnings of $0.16 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 75%. The business is expected to report its next earnings results on Monday, January 1st.
According to Zacks, analysts expect that Joint will report full-year earnings of $0.33 per share for the current financial year, with EPS estimates ranging from $0.32 to $0.33. For the next fiscal year, analysts anticipate that the business will report earnings of $0.55 per share, with EPS estimates ranging from $0.49 to $0.61. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Joint.
Joint (NASDAQ:JYNT – Get Rating) last released its quarterly earnings results on Thursday, February 24th. The company reported $0.01 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.07). Joint had a net margin of 8.82% and a return on equity of 26.30%. The company had revenue of $22.43 million during the quarter, compared to analyst estimates of $22.21 million. During the same quarter last year, the business earned $0.12 EPS.
Shares of NASDAQ:JYNT traded up $1.29 during midday trading on Thursday, reaching $35.13. The company had a trading volume of 1,217 shares, compared to its average volume of 283,569. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.25 and a current ratio of 1.25. Joint has a 1-year low of $29.84 and a 1-year high of $111.06. The firm has a market cap of $506.22 million, a price-to-earnings ratio of 70.50 and a beta of 1.27. The company has a fifty day simple moving average of $40.95 and a two-hundred day simple moving average of $63.43.
In other news, CEO Peter D. Holt purchased 1,500 shares of the business’s stock in a transaction dated Wednesday, March 16th. The stock was bought at an average cost of $33.24 per share, with a total value of $49,860.00. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Jake Singleton purchased 1,515 shares of the business’s stock in a transaction dated Wednesday, March 16th. The shares were purchased at an average cost of $33.00 per share, with a total value of $49,995.00. The disclosure for this purchase can be found here. 4.60% of the stock is owned by company insiders.
Hedge funds and other institutional investors have recently modified their holdings of the company. Captrust Financial Advisors increased its holdings in shares of Joint by 117.6% during the 3rd quarter. Captrust Financial Advisors now owns 285 shares of the company’s stock valued at $28,000 after acquiring an additional 154 shares during the last quarter. Pinebridge Investments L.P. acquired a new position in shares of Joint during the 4th quarter valued at about $33,000. Point72 Hong Kong Ltd acquired a new position in shares of Joint during the 4th quarter valued at about $36,000. USA Financial Portformulas Corp acquired a new position in shares of Joint during the 3rd quarter valued at about $59,000. Finally, PNC Financial Services Group Inc. increased its holdings in shares of Joint by 73.3% during the 3rd quarter. PNC Financial Services Group Inc. now owns 629 shares of the company’s stock valued at $62,000 after acquiring an additional 266 shares during the last quarter. 86.71% of the stock is currently owned by institutional investors and hedge funds.
About Joint (Get Rating)
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.
- Get a free copy of the StockNews.com research report on Joint (JYNT)
- Greenbrier Companies Stock has Green in its Future
- Insiders Are Selling Palo Alto Networks
- 3 Bank Stocks That Are Ready to Handle Whatever the Fed Throws at Them
- Tilray Stock Has Better Days Ahead
- Headwinds Mount For Carmax, Don’t Count On Higher Share Prices
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.